Absorption |
Blood-Brain Barrier | BBB- | 0.9651 |
Human Intestinal Absorption | HIA+ | 0.9914 |
Caco-2 Permeability | Caco2+ | 0.9002 |
P-glycoprotein Substrate | Substrate | 0.8136 |
P-glycoprotein Inhibitor | Non-inhibitor | 0.8781 |
Non-inhibitor | 0.8382 |
Renal Organic Cation Transporter | Non-inhibitor | 0.6812 |
Distribution |
Subcellular localization | Lysosome | 0.3838 |
Metabolism |
CYP450 2C9 Substrate | Non-substrate | 0.8645 |
CYP450 2D6 Substrate | Non-substrate | 0.9116 |
CYP450 3A4 Substrate | Non-substrate | 0.6809 |
CYP450 1A2 Inhibitor | Non-inhibitor | 0.9275 |
CYP450 2C9 Inhibitor | Non-inhibitor | 0.9206 |
CYP450 2D6 Inhibitor | Non-inhibitor | 0.9112 |
CYP450 2C19 Inhibitor | Non-inhibitor | 0.8584 |
CYP450 3A4 Inhibitor | Non-inhibitor | 0.9524 |
CYP Inhibitory Promiscuity | Low CYP Inhibitory Promiscuity | 0.6784 |
Excretion |
Toxicity |
Human Ether-a-go-go-Related Gene Inhibition | Weak inhibitor | 0.7983 |
Non-inhibitor | 0.7795 |
AMES Toxicity | AMES toxic | 0.9108 |
Carcinogens | Non-carcinogens | 0.8816 |
Fish Toxicity | High FHMT | 0.9986 |
Tetrahymena Pyriformis Toxicity | High TPT | 0.9611 |
Honey Bee Toxicity | Low HBT | 0.8887 |
Biodegradation | Not ready biodegradable | 1.0000 |
Acute Oral Toxicity | III | 0.8243 |
Carcinogenicity (Three-class) | Non-required | 0.6183 |